The ACE I allele is associated with increased risk for ruptured intracranial aneurysms

Journal of Medical Genetics

Volumn 37, Issue 7, 2000, Pages 498-500

  Keramatipour, Mohammad ^a   McConnell, Robert S ^b   Kirkpatrick, Peter ^b   Tebbs, Susan ^b   Furlong, Robert A ^a   Rubinsztein, David C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

ACE I allele; Ruptured intracranial aneurysms

Indexed keywords

ADULT; AGED; ALLELE; ANEURYSM RUPTURE; ARTICLE; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC RISK; HUMAN; INTRACRANIAL ANEURYSM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033937246     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.37.7.498     Document Type: Article

References (28)

1. Schievink WI, Wijdicks EF, Parisi JE, Piepgras DG, Whisnant JP. Sudden death from aneurysmal subarachnoid hemorrhage. Neurology 1995;45:871-4.
2. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1. Overall management results. J Neurosurg 1990;73:18-36.
3. Butler WE, Barker FG II, Crowell RM. Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: a decision analysis. Neurosurgery 1996;38:506-15.
4. Schievink WI, Limburg M, Oorthuys JW, Fleury P, Pope FM. Cerebrovascular disease in Ehlers-Danlos syndrome type IV. Stroke 1990;21:626-32.
5. Leblanc R, Melanson D, Tampieri D, Guttmann RD. Familial cerebral aneurysms: a study of 13 families. Neurosurgery 1995;37:633-8.
6. Bromberg JE, Rinkel GJ, Algra A, Greebe P, van Duyn CM, Hasan D, Limburg M, ter Berg HW, Wijdicks EF, van Gijn J. Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ 1995;311:288-9.
7. De Braekeleer M, Perusse L, Cantin L, Bouchard JM, Mathieu J. A study of inbreeding and kinship in intracranial aneurysms in the Saguenay Lac-Saint-Jean region (Quebec, Canada). Ann Hum Genet 1996;60:99-104.
8. Taylor CL, Yuan Z, Selman WR, Ratcheson RA, Rimm AA. Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: hypertension and other risk factors. J Neurosurg 1995;83:812-19.
9. Knekt P, Reunanen A, Aho K, Heliovaara M, Rissanen A, Aromaa A, Impivaara O. Risk factors for subarachnoid hemorrhage in a longitudinal population study. J Clin Epidemiol 1991;44:933-9.
10. Alberts MJ, Quinones A, Graffagnino C, Friedman A, Roses AD. Risk of intracranial aneurysms in families with subarachnoid hemorrhage. Can J Neurol Sci 1995;22:121-5.
11. Ganong WF. Review of medical physiology. 10th ed. Los Alton: Lange Medical Publications, 1981:364-5.
12. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86: 1343-6.
13. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P Soubrier F, Alhenc-Gelas F. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994;90:669-76.
14. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD geno-type of the angiotensin-converting enzyme is a risk factor for left ventricular hypertrophy. Circulation 1994;90:2622-8.
15. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994;267:H1107-11.
16. O'Byrne S, Caulfield M. Genetics of hypertension. Therapeutic implications. Drugs 1998;56:203-14.
17. Kehoe PG, Russ C, McIlroy S, Williams H, Holmans P, Holmes C, Liolitsa D, Vahidassr D, Powell J, McGleenon B, Liddell M, Plomin R, Dynan K, Williams N, Neal J, Cairns NJ, Wilcock G, Passmore P, Lovestone S, Williams J, Owen MJ. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet 1999;21:71-2.
18. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic association with human longevity with the APOE and ACE loci. Nat Genet 1994;6:29-32.
19. Galinsky D, Tysoe C, Brayne CE, Easton DF, Huppert FA, Dening TR, Paykel ES, Rubinsztein DC. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylene tetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 1997; 129:177-83.
20. Catto A, Carter AM, Barrett JH, Stickland M, Bamford J, Davies JA, Grant PJ. Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke 1996;27:435-40.
21. Takenaka K, Yamakawa H, Sakai H, Yoshimura S, Murase S, Okumura A, Nakatani K, Kimura T, Nishimura Y, Yoshimi N, Sakai N. Angiotensin I-converting enzyme gene polymorphism in intracranial saccular aneurysm individuals. Neurol Res 1998;20:607-11.
22. Todd JA. Interpretation of results from genetic studies of multifactorial diseases. Lancet 1999;354:SI15-16.
23. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, O'Rourke DF, Cambien F. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med 1994;87:211-14.
24. Rosatto N, Pontremoli R, De Ferrari G, Ravazzolo R. Intron 16 insertion of the angiotensin converting enzyme gene and transcriptional regulation. Nephrol Dial Transplant 1999;14: 868-71.
25. Youmans JR, ed. Neurological surgery. Philadelphia: Saunders, 1982:1627.
26. Falkenhahn M, Gohlke P, Paul M, Stoll M, Unger T. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects. J Cardiovasc Pharmacol 1994; 24(suppl 2):S6-13.
27. Dzau VJ. Cell biology and genetics of angiotensin in cardiovascular disease. J Hypertens Suppl 1994;12:S3-10.
28. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995;47:25-49.